Oct 13, 2026 07:47AM
Oct 5, 2026 07:45AM
Sep 23, 2026 04:45AM
Sep 14, 2026 07:46AM
Aug 18, 2026 04:15AM
Jun 16, 2026 05:17AM
Apr 27, 2026 01:58AM Citizens Starts TuHURA Biosciences (HURA) at Market Outperform
Apr 15, 2026 08:08AM
Apr 8, 2026 04:35PM
Apr 7, 2026 07:47AM
Mar 24, 2026 10:30AM
Mar 23, 2026 07:45AM
Feb 17, 2026 07:46AM
Feb 2, 2026 07:45AM TuHURA Biosciences receives FDA orphan drug designation for melanoma treatment
Dec 15, 2025 07:51AM
Dec 11, 2025 07:30AM
Dec 8, 2025 07:50AM
Nov 14, 2025 07:50AM
Nov 3, 2025 09:02AM
Aug 22, 2025 06:58AM
Jul 1, 2025 08:50AM TuHURA Biosciences (HURA) added to Russell 2000 and 3000
Jun 30, 2025 08:51AM
Jun 30, 2025 06:52AM
Jun 24, 2025 08:04AM
Jun 23, 2025 05:02PM
Jun 23, 2025 09:16AM
Jun 9, 2025 10:12AM
Jun 9, 2025 08:01AM TuHURA Biosciences (HURA) Says FDA Removed Partial Clinical Hold on Phase 3 Accelerated Approval Trial for IFx-2.0
Jun 3, 2025 10:00AM
May 5, 2025 08:06AM
Apr 28, 2025 08:04AM
Apr 7, 2025 08:25AM
Apr 3, 2025 06:45AM
Mar 11, 2025 08:05AM
Mar 10, 2025 09:00AM TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference
Feb 19, 2025 09:00AM
Dec 19, 2024 05:48AM
Dec 13, 2024 01:21PM
Dec 12, 2024 08:46AM
Dec 12, 2024 08:45AM
Nov 25, 2024 08:39AM
Nov 25, 2024 08:35AM TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma
Oct 23, 2024 08:30AM
Oct 22, 2024 09:00AM
Oct 17, 2024 04:38PM
Oct 17, 2024 04:35PM

481,541 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All